|
1.1 BIOLOGIE - GÉNOME
|
|
|
|
|
2.6 ETIOLOGIE - ENVIRONNEMENT
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
3.2 PRÉVENTION - OBÉSITÉ
|
|
|
|
3.8 PRÉVENTION - ALIMENTATION
|
|
|
Men who eat yogurt may have lower colon cancer risk [Reuters]
|
|
|
|
|
|
Researchers examined data on 32,606 male and 55,743 female health professionals who had a colonoscopy between 1986 and 2012. Study participants provided detailed information about their health, lifestyle, eating and exercise habits every four years.
|
|
|
|
|
|
|
4.2 DÉP., DIAG. & PRONO. - GÉNOME
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
|
|
5.12 IMMUNOTHÉRAPIES
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
|
|
|
|
5.12.8 IMMUNOTHÉRAPIES - ECONOMIE
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
Call for all sponsors to publish clinical trial results in EU database [EMA]
|
|
|
|
|
|
The European Commission (EC), the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have co-signed a letter reminding all sponsors of clinical trials conducted in the European Union of their obligation to make summaries of results of concluded trials publicly available in the EU Clinical Trials Database.
|
|
|
|
|
|
|
5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)
|
|
|
|
|
FDA grants accelerated approval to selinexor for multiple myeloma [FDA]
|
|
|
|
|
|
Efficacy was evaluated in 122 patients enrolled in Part 2 of STORM (KCP-330-012; NCT02336815), a multicenter, single-arm, open-label study of patients with RRMM who had previously received three or more anti-myeloma treatment regimens including an alkylating agent, glucocorticoids, bortezomib, carfilzomib, lenalidomide, pomalidomide, and an anti-CD38 monoclonal antibody.
|
|
|
|
|
|
|
6.1 OBSERVATION
|
|
|
|
|
6.4 MÉDICO-ÉCO
|
|
|
|
|
6.7.1 IA/BIOINFORMATIQUE
|
|
|
|
6.8 COMMUNICATION
|
|
|